Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

262 ARTíCULOS , VIENDO DEL 16 AL 30

PUBMED

TRPC5 channel instability induced by depalmitoylation protects striatal neurons against oxidative stress in Huntington's disease.

Hong C, Choi SH, Kwak M, Jeong B, Ko J, Park HJ, Choi S, Jun JY, So I.

Biochim Biophys Acta Mol Cell Res. 2020 Feb;1867(2):118620. doi: 10.1016/j.bbamcr.2019.118620. Epub 2019 Dec 6.

0

0

0

PUBMED

Spatiotemporal gait characteristics of Huntington's disease during dual-task walking.

Radovanović S, Vodopić S, Stanković I, Dragašević-Mišković N, Kostić V.

Int J Neurosci. 2020 Feb;130(2):136-143. doi: 10.1080/00207454.2019.1667781. Epub 2019 Oct 2.

0

0

0

PUBMED

Impaired face-like object recognition in premanifest Huntington's disease.

Martínez-Horta S, Horta-Barba A, Perez-Perez J, Antoran M, Pagonabarraga J, Sampedro F, Kulisevsky J.

Cortex. 2020 Feb;123:162-172. doi: 10.1016/j.cortex.2019.10.015. Epub 2019 Nov 13.

0

0

0

PUBMED

Enhanced striatopallidal gamma-aminobutyric acid (GABA)(A) receptor transmission in mouse models of huntington's disease.

Perez-Rosello T, Gelman S, Tombaugh G, Cachope R, Beaumont V, Surmeier DJ.

Mov Disord. 2019 May;34(5):684-696. doi: 10.1002/mds.27622. Epub 2019 Feb 6.

0

0

0

PUBMED

Manganese Acts upon Insulin/IGF Receptors to Phosphorylate AKT and Increase Glucose Uptake in Huntington's Disease Cells.

Bryan MR, Nordham KD, Rose DIR, O'Brien MT, Joshi P, Foshage AM, Gonçalves FM, Nitin R, Uhouse MA, Aschner M, Bowman AB.

Mol Neurobiol. 2019 Dec 4. doi: 10.1007/s12035-019-01824-1. [Epub ahead of print]

0

0

0

PUBMED

Clinical manifestations of homozygote allele carriers in Huntington disease.

Cubo E, Martinez-Horta SI, Santalo FS, Descalls AM, Calvo S, Gil-Polo C, Muñoz I, Llano K, Mariscal N, Diaz D, Gutierrez A, Aguado L, Ramos-Arroyo MA; European HD Network..

Neurology. 2019 Apr 30;92(18):e2101-e2108. doi: 10.1212/WNL.0000000000007147. Epub 2019 Mar 13.

0

0

0

PUBMED

[Application of high-throughput whole genome sequencing and STR typing for the analysis of chorea villus tissue samples from spontaneous abortion].

Zhang J, Wang S, Yang Y, Zhang J, Wu X, Chen C, Yao F, Zhang Y.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2019 Dec 10;36(12):1171-1174. doi: 10.3760/cma.j.issn.1003-9406.2019.12.005. Chinese.

0

0

0

PUBMED

Deregulated Splicing Is a Major Mechanism of RNA-Induced Toxicity in Huntington's Disease.

Schilling J, Broemer M, Atanassov I, Duernberger Y, Vorberg I, Dieterich C, Dagane A, Dittmar G, Wanker E, van Roon-Mom W, Winter J, Krauß S.

J Mol Biol. 2019 Apr 19;431(9):1869-1877. doi: 10.1016/j.jmb.2019.01.034. Epub 2019 Jan 31.

0

0

0

PUBMED

Huntington's disease patients display progressive deficits in hippocampal-dependent cognition during a task of spatial memory.

Harris KL, Armstrong M, Swain R, Erzinclioglu S, Das T, Burgess N, Barker RA, Mason SL.

Cortex. 2019 Oct;119:417-427. doi: 10.1016/j.cortex.2019.07.014. Epub 2019 Aug 13.

0

0

0

PUBMED

Huntington disease: A quarter century of progress since the gene discovery.

Testa CM, Jankovic J.

J Neurol Sci. 2019 Jan 15;396:52-68. doi: 10.1016/j.jns.2018.09.022. Epub 2018 Sep 27. Review.

0

0

0

PUBMED

Vildagliptin Attenuates Huntington's Disease through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model.

Sayed NH, Fathy N, Kortam MA, Rabie MA, Mohamed AF, Kamel AS.

Neurotherapeutics. 2020 Jan;17(1):252-268. doi: 10.1007/s13311-019-00805-5.

0

0

0

PUBMED

Paliperidone Long-Acting Injections in Huntington's Disease for Motor and Behavioural Disturbances.

van Oosterom N, Theodoros T.

Clin Drug Investig. 2019 Apr;39(4):407-410. doi: 10.1007/s40261-019-00759-8.

0

0

0

PUBMED

Huntingtin Lowering Strategies for Disease Modification in Huntington's Disease.

Tabrizi SJ, Ghosh R, Leavitt BR.

Neuron. 2019 Mar 6;101(5):801-819. doi: 10.1016/j.neuron.2019.01.039. Review.

0

0

0

PUBMED

Antisense oligonucleotides might change the therapeutic landscape for Huntington's disease.

Paulsen JS, Coffey CS.

Lancet Neurol. 2019 Oct;18(10):911-912. doi: 10.1016/S1474-4422(19)30329-1. No abstract available.

0

0

0

PUBMED

Sydenham's Chorea.

Risavi BL, Iszkula E, Yost B.

J Emerg Med. 2019 Apr 16. pii: S0736-4679(19)30099-X. doi: 10.1016/j.jemermed.2019.02.012. [Epub ahead of print]

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy